NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer

BACKGROUND: Neuronatin (NNAT) was recently identified as a novel mediator of estrogen receptor-positive (ER+) breast cancer cell proliferation and migration, which correlated with decreased tumorigenic potential and prolonged patient survival. However, despite these observations, the molecular and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Plasterer, Cody, Semenikhina, Marharyta, Tsaih, Shirng-Wern, Flister, Michael J, Palygin, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318825/
https://www.ncbi.nlm.nih.gov/pubmed/37400769
http://dx.doi.org/10.1186/s10020-023-00673-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318825/
https://www.ncbi.nlm.nih.gov/pubmed/37400769
http://dx.doi.org/10.1186/s10020-023-00673-y

Ejemplares similares